Streamlined Clinical Trial Feasibility: The Key That Unlocks The Site-Sponsor Relationship

Determining the feasibility of a site for clinical research is a critical component of the entire trial process. Too often, however, the feasibility process is disjointed, involving multiple disparate systems and rounds of data gathering across sponsors. This commonly results in duplicated work efforts, extended cycle times and discontented site staff who are responsible for answering the same, or similar, questions from multiple sponsors.

A recent research statement by the American Society of Cancer Oncology called the feasibility assessment process inefficient, highlighting both the number of questions in each feasibility survey and their repetitive nature across surveys. ASCO’s research also found that sites spend a median of 264 hours completing feasibility assessments each year—for the entire life sciences industry, this equates to an estimated $1.6 billion and tens of millions of work hours per year.

Ultimately, the inefficiency and strained relationship limits the number and types of studies sponsors and clinical research organizations (CROs) can conduct, raising the cost of developing new treatments and delaying their arrival to market.

Learn how automation and standardization can improve the site-sponsor journey and streamline clinical trial feasibility.